Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Pflugers Arch. 2012 Sep 12;464(4):415–423. doi: 10.1007/s00424-012-1150-7

Fig. 3.

Fig. 3

Effect of Ac-SDKP on SHP-2 activity in cardiac fibroblasts treated with ET-1 for 10 minutes. ET-1 significantly reduced SHP-2 activity and this was prevented by Ac-SDKP. * p < 0.001, ET-1 alone vs control; † p < 0.001, Ac-SDKP plus ET-1 vs ET-1 alone (n = 5 per group)